Cargando…

Imatinib reduces non-alcoholic fatty liver disease in obese mice by targeting inflammatory and lipogenic pathways in macrophages and liver

Macrophages have been recognized as key players in non-alcoholic fatty liver disease (NAFLD). Our aim was to assess whether pharmacological attenuation of macrophages can be achieved by imatinib, an anti-leukemia drug with known anti-inflammatory and anti-diabetic properties, and how this impacts on...

Descripción completa

Detalles Bibliográficos
Autores principales:	AlAsfoor, Shefaa, Rohm, Theresa V., Bosch, Angela J. T., Dervos, Thomas, Calabrese, Diego, Matter, Matthias S., Weber, Achim, Cavelti-Weder, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193017/ https://www.ncbi.nlm.nih.gov/pubmed/30333571 http://dx.doi.org/10.1038/s41598-018-32853-w

Ejemplares similares

Lung versus gut exposure to air pollution particles differentially affect metabolic health in mice
por: Bosch, Angela J. T., et al.
Publicado: (2023)

Diesel Exhaust Particle (DEP)-induced glucose intolerance is driven by an intestinal innate immune response and NLRP3 activation in mice
por: Bosch, Angela J. T., et al.
Publicado: (2023)

Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity
por: Rohm, Theresa V., et al.
Publicado: (2022)

Fatty liver disrupts glycerol metabolism in gluconeogenic and lipogenic pathways in humans
por: Jin, Eunsook S., et al.
Publicado: (2018)

Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression
por: Deenin, Wanwisa, et al.
Publicado: (2021)

Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation
por: Rohm, Theresa V., et al.
Publicado: (2021)

Low-ω3 Fatty Acid and Soy Protein Attenuate Alcohol-Induced Fatty Liver and Injury by Regulating the Opposing Lipid Oxidation and Lipogenic Signaling Pathways
por: Reyes-Gordillo, Karina, et al.
Publicado: (2016)

Increased serum levels of lipogenic enzymes in patients with severe liver steatosis
por: Notarnicola, Maria, et al.
Publicado: (2012)

Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
por: Thibaut, Ronan, et al.
Publicado: (2021)

Statin Treatment Induced a Lipogenic Expression Hierarchical Network Centered by SREBF2 in the Liver
por: Song, Shiyu, et al.
Publicado: (2021)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis
por: Ni, Yinhua, et al.
Publicado: (2016)

Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients
por: Kirchner, Henriette, et al.
Publicado: (2016)

Prebiotic and Synbiotic Modifications of Beta Oxidation and Lipogenic Gene Expression after Experimental Hypercholesterolemia in Rat Liver
por: Alves, Claudia C., et al.
Publicado: (2017)

Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligands
por: Belorusova, Anna Y., et al.
Publicado: (2019)

Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
por: Lefere, Sander, et al.
Publicado: (2019)

The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
por: Kohlhepp, Marlene Sophia, et al.
Publicado: (2023)

Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
por: Martínez–Sánchez, Celia, et al.
Publicado: (2023)

Effects of Male Hypogonadism on Regional Adipose Tissue Fatty Acid Storage and Lipogenic Proteins
por: Santosa, Sylvia, et al.
Publicado: (2012)

Comparative Effects of Fructose and Glucose on Lipogenic Gene Expression and Intermediary Metabolism in HepG2 Liver Cells
por: Hirahatake, Kristin M., et al.
Publicado: (2011)

Liver-Specific PGC-1beta Deficiency Leads to Impaired Mitochondrial Function and Lipogenic Response to Fasting-Refeeding
por: Chambers, Kari T., et al.
Publicado: (2012)

Macrophages in metabolic associated fatty liver disease
por: Alharthi, Jawaher, et al.
Publicado: (2020)

Macrophage metabolism in nonalcoholic fatty liver disease
por: Zhang, Wenhui, et al.
Publicado: (2023)

Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack
por: Oates, Jarren R., et al.
Publicado: (2019)

Role of DNA Methylation in the Regulation of Lipogenic Glycerol-3-Phosphate Acyltransferase 1 Gene Expression in the Mouse Neonatal Liver
por: Ehara, Tatsuya, et al.
Publicado: (2012)

Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver
por: Kurtz, C. Lisa, et al.
Publicado: (2015)

SUN-740 Low-Dose Dihydrotestosterone Lowers Lipogenic Master Regulator in Liver and Adipose Tissue from Female Mice
por: Seidu, Tina, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile, and Macrophage Polarization
por: Du, Yong, et al.
Publicado: (2021)

Changes in Function and Dynamics in Hepatic and Splenic Macrophages in Non-Alcoholic Fatty Liver Disease
por: Fukushima, Hisataka, et al.
Publicado: (2020)

Macrophages and scavenger receptors in obesity‐associated non‐alcoholic liver fatty disease (NAFLD)
por: Kragh Petersen, Sine, et al.
Publicado: (2020)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2‐Dependent Mitotic Cell Death
por: Rios Garcia, Marcos, et al.
Publicado: (2022)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Stem cell approaches for diabetes: towards beta cell replacement
por: Weir, Gordon C, et al.
Publicado: (2011)

Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism
por: Sarcevic, Jelena, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers
por: Anavi, Sarit, et al.
Publicado: (2017)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Ramai, Daryl, et al.
Publicado: (2021)

Hepatic Macrophage as a Key Player in Fatty Liver Disease
por: Xu, Liyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_73ti92ota455rkfgr8iiqomhvt